Dyne Therapeutics, Inc.
DYN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$317 | -$236 | -$168 | -$149 |
| Dep. & Amort. | -$2 | $2 | $2 | $1 |
| Deferred Tax | $0 | $0 | $0 | $3 |
| Stock-Based Comp. | $46 | $20 | $15 | $18 |
| Change in WC | -$19 | $26 | -$5 | $9 |
| Other Non-Cash | $1 | -$0 | $3 | -$1 |
| Operating Cash Flow | -$292 | -$188 | -$154 | -$120 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$2 | -$1 | -$3 | -$4 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$317 | -$44 | -$121 | -$237 |
| Inv. Sales/Matur. | $116 | $128 | $211 | $102 |
| Other Inv. Act. | $0 | $0 | -$0 | -$0 |
| Investing Cash Flow | -$204 | $83 | $87 | -$138 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $773 | $52 | $37 | $157 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $37 | $2 | $1 | $1 |
| Financing Cash Flow | $810 | $54 | $37 | $158 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $313 | -$51 | -$29 | -$100 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $124 | $174 | $204 | $303 |
| End Cash | $437 | $124 | $174 | $204 |
| Free Cash Flow | -$295 | -$189 | -$157 | -$123 |